180 results
Page 2 of 9
6-K
EX-99.1
l2psw
5 May 23
Galapagos announces first quarter 2023 financial results
4:05pm
6-K
EX-99.1
c76o6 qjb38ogngv39k
2 May 23
Current report (foreign)
4:15pm
6-K
EX-99.1
tkt 7uv4a
23 Dec 22
Galapagos announces changes to Executive Committee
6:05am
6-K
EX-99.1
82wtwv65bdsyxeg7or
13 Dec 22
Galapagos and CellPoint presented encouraging initial data at ASH 2022 for GLPG5101, a CD19 CAR-T candidate manufactured at point-of-care
7:49am
6-K
EX-99.1
mehjmq4ba
14 Nov 22
Current report (foreign)
6:05am
6-K
EX-99.1
xoh4xc pkg
9 Nov 22
Current report (foreign)
4:05pm
6-K
EX-99.1
viei174ahgqswzp720s
7 Nov 22
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
6:08am
6-K
EX-99.2
w1dcmpww
7 Nov 22
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
6:08am
6-K
EX-99.1
r94zkh715
4 Nov 22
Galapagos presents roadmap for pipeline and commercial growth at its R&D Day 2022
4:57pm
6-K
EX-99.1
firv6hnm84sl
6 Oct 22
Current report (foreign)
5:11pm
6-K
EX-99.1
a1xn m93ftwhyne
3 Oct 22
Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies
6:02pm
6-K
EX-99.1
z38qmeaox49ejfdk
8 Aug 22
First key steps in pipeline rebuild and strong commercial progress in H1 2022
4:59pm
6-K
EX-99.2
y0ydj80816k1cu17
8 Aug 22
First key steps in pipeline rebuild and strong commercial progress in H1 2022
4:59pm
6-K
EX-99.1
5p206dsu9fcoph
31 May 22
Current report (foreign)
1:39pm
6-K
EX-99.2
d9rjbo0va 4rrtbju
6 May 22
Current report (foreign)
5:18pm
6-K
EX-99.1
tgq9956p
6 May 22
Current report (foreign)
5:18pm
6-K
EX-99.3
y9bu 9oz9b
11 Apr 22
Current report (foreign)
5:14pm
6-K
EX-99.1
axivcbhjmnzujdk37ed
28 Mar 22
Jyseleca® approved in Japan for ulcerative colitis
1:50pm
6-K
EX-99.1
sbrfgfe 4i31wy
24 Feb 22
Galapagos 2021 results set stage for future growth
5:19pm